© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
May 30, 2020
The HIF-2a Inhibitor induced clinical responses among patients with von Hippel-Lindau disease–associated kidney cancer, according to results presented at the 2020 ASCO Virtual Scientific Program.
Roundup Herbicide Will Ditch Glyphosate, the Chemical Linked to Cancer
Keeping Faith After a Sarcoma Diagnosis
Bladder Cancer Treatment May Negatively Impact Patients’ Psychosocial Well-being
Why Isn’t Sunscreen Marketed to Men?